Home LiteratureArticle Details
PMID: 876721 Published · ppublish English Journal Article

Long-term outcome of Hemophilus influenzae meningitis related to antiobiotic treatment.

Pediatrics ·Vol. 60 ·No. 1 ·1977-07-00 ·Pages 1-6

Lindberg J, Rosenhall U, Nylén O, Ringnér A

Abstract

Of 82 patients treated for Hemophilus influenzae meningitis from 1968 to 1975, a total of 22 (26.8%) showed neurologic or psychologic sequelae, or both. Auditory impairment was the most common type of sequelae; it occurred in 15 patients. Complications during acute illness were more frequent in patients who later developed sequelae than in patients who recovered completely. Sequelae were more often found in patients who received both ampicillin and chloramphenicol concomitantly compared with patients who were treated with one of these drugs. A possible antagonistic interaction between ampicillin and chloramphenicol is discussed.

MeSH Terms
Ampicillin/therapeutic use Anti-Bacterial Agents/therapeutic use Child Child, Preschool Chloramphenicol/therapeutic use Female Follow-Up Studies Hearing Disorders/etiology Humans Hydrocephalus/etiology Infant Intellectual Disability/etiology Male Meningitis, Haemophilus/complications,drug therapy,epidemiology Penicillin G/therapeutic use Psychomotor Disorders/etiology Sulfonamides/therapeutic use Sweden
Chemicals
Anti-Bacterial Agents Sulfonamides Chloramphenicol Ampicillin Penicillin G
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lindberg J
Rosenhall U
Nylén O
Ringnér A
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
0031-4005
Published
1977-07-00
Pages
1-6
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com